Simplicity Solutions’s Forte Biosciences FBRX Stock Holding History

Simplicity Solutions’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-748	Closed	-$24K	–	662
2022 Q2	$24K	Buy	+748	New	+$23.8K	﹤0.01%	625

Other funds holding FBRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

OWP

Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplicity Solutions's FBRX Position: Q3 2022 in Review

Simplicity Solutions sold out of Forte Biosciences (FBRX) in Q3 2022, closing a stake of 748 shares — an estimated $24K sold.

Simplicity Solutions first reported a position in FBRX in Q2 2022 and held it in 1 quarter. The position peaked at $24K in Q2 2022. 33 funds tracked by Wall St. Rank hold FBRX as of Q3 2022.

Simplicity Solutions reported no remaining Forte Biosciences position as of Q3 2022 after selling out during the quarter.
Simplicity Solutions sold 748 Forte Biosciences shares in Q3 2022, an estimated $24K.
Simplicity Solutions first reported a position in Forte Biosciences in Q2 2022 and held it in 1 quarter.
Simplicity Solutions's Forte Biosciences position peaked at $24K in Q2 2022.
33 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2022.

Based on Simplicity Solutions's 13F filing for Q3 2022, filed 12 Oct 2022.